During the past decade, Oncologia Varini&Calderoni&Christinat conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Oncologia Varini&Calderoni&Christinat" are "Bone Metastases" (1 trials), "Early Breast Cancer" (1 trials), "Metastatic Breast Cancer" (1 trials) and "Metastatic Prostate Cancer" (1 trials). Many other conditions were trialed in "Oncologia Varini&Calderoni&Christinat" in a lesser frequency.

Most popular intervention types in "Oncologia Varini&Calderoni&Christinat" are "Behavioral" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Activity program" (1 trials), "Control" (1 trials), "Denosumab (reduced dosing)" (1 trials) and "Denosumab (standard dosing)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Oncologia Varini&Calderoni&Christinat" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Oncologia Varini&Calderoni&Christinat". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Oncologia Varini&Calderoni&Christinat, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Oncologia Varini&Calderoni&Christinat, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".